translational research

One Foundation’s Mission Translates to Impact

Feline Infectious Peritonitis, also known as FIP, is one of the deadliest diseases in cats. Tragically, it affects kittens the most, and is often fatal if untreated. Cats may carry the feline coronavirus without issue, but in some, a mutation causes it to develop into FIP, which can turn fatal.

UC Davis Welcomes Equine Surgeon and Orthopedic Researcher Dr. Heidi Reesink

 

The UC Davis School of Veterinary Medicine is pleased to welcome Dr. Heidi Reesink as a Professor of Veterinary Orthopedics. A board-certified surgeon, Dr. Reesink will have a clinical appointment with the Veterinary Medical Teaching Hospital’s (VMTH) Equine Surgery and Lameness Service, as well as a research laboratory within the school’s J.D. Wheat Veterinary Orthopedic Laboratory.

Among the Academies: Transforming Lives Before Birth

As one of the world’s first fetal surgeons, Diana Farmer has long been focused on the smallest of patients.

She specializes in treating birth defects inside and outside of the womb, treating congenital anomalies and cancer and performing airway and intestinal surgeries. In the late 1990s, she became the first woman in the world to perform open fetal surgery.

One Health Collaboration Spotlights Disparities in Knee and Jaw Joint Treatments

There are many similarities between the usage, and consequent injury, in knee joints and the jaw’s temporomandibular joint (TMJ). However, knee orthopedics are better researched and funded, resulting in tissue-engineered products and other ways to improve the lives of those affected. Dr. Boaz Arzi, professor and dentist/maxillofacial surgeon with the UC Davis School of Veterinary Medicine, joined biomedical engineers and orthopedic surgeons from UC Irvine, orthopedic surgeons from Harvard University, oral/maxillofacial surgeons from the University of Texas, and oral/maxillofacial radiologists to research the subject further.

Training the Next Generation of Comparative Oncologists

UC Davis is taking a major leap forward in training the next generation of scientists engaged in basic and translational cancer research for animals and humans, thanks to a prestigious National Institutes of Health (NIH) T32 grant.